First Tracks Biotherapeutics, Inc.

• First Tracks Biotherapeutics Inc Estimates – FWB:B43
  TradingView · 23 Oct 2026
• First Tracks Biotherapeutics Closes Private Placement, Grants Registration Rights for 6.1M Shares
  TradingView · 20 Oct 2026
• First Tracks lines up USD 200 million raise after positive celiac disease trial
  AllSci · 16 Oct 2026
• First Tracks Biotherapeutics Secures $200 Million Private Placement at $32.75 Per Share
  TradingView · 15 Oct 2026
• First Tracks Biotherapeutics announces $200M private placement
  TradingView · 15 Oct 2026
• First Tracks Biotherapeutics raises $200M in private placement
  Investing.com · 15 Oct 2026
• First Tracks' ANB033 meets histologic endpoints in Phase Ib celiac disease trial
  AllSci · 13 Oct 2026
• First Tracks Biotherapeutics stock surges 20% on celiac trial data
  Investing.com · 12 Oct 2026
• First Tracks Biotherapeutics Announces Positive Top-Line
  GlobeNewswire · 12 Oct 2026
• First Tracks climbs on ‘impressive’ celiac study data
  BioPharma Dive · 12 Oct 2026
• Why is First Tracks Biotherapeutics stock surging today?
  Investing.com · 12 Oct 2026
• First Tracks Biotherapeutics Announces Positive Top-Line Results For ANB033 In Gluten-Challenge Study In Celiac Disease
  TradingView · 12 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →